Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has issued duplicate share certificates in respect of Share Certificates reported to be lost by the shareholders. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Name of the Shareholder Folio no. No. of shares Old Certificate Nos. Distinctive Nos. New Certificate No. Renuka Bhatia 11551 200 91966 - 91967 77350101-77350300 209383 Paramjit Singh 10963 200 88587 - 88588 77012201-77012400 209382 Shri Niwas Garg 3039 200 194436 - 194437 70423401- 70423600 209381 This is for your information and record.
18-01-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Shareholding for the Period Ended December 31, 2021

 Indraprastha Medical Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here
18-01-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Statement Of Investor Complaints For The Quarter Ended December 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 01073 Name of the Signatory :- Priya RanjanDesignation :- Company Secretary and Compliance Officer
17-01-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window

 Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st January, 2022 till 48 hours after the declaration of unaudited financial results for the quarter ending 31st December, 2021. The date of the Board Meeting to consider the unaudited financial results for the quarter ending 31st December, 2021, shall be intimated separately. This is for your information and record.
23-12-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has received intimation from a shareholder on 13th December, 2021, regarding loss of share certificates. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Name of the Shareholder Folio no. No. of shares Certificate Nos. Distinctive Nos. Shri Niwas Garg 3039 200 194436 - 194437 70423401 - 70423600 This is for your information and record.
14-12-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has received intimation from a shareholder on 7th December, 2021, regarding loss of share certificates. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Name of the Shareholder - Paramjit Singh Folio No. - 10963 No. of shares - 200 Certificate Nos. - 88587 - 88588 Distinctive Nos. - 77012201 - 77012400 This is for your information and record.
08-12-2021
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Disclosure Of Related Party Transactions For The Half Year Ended 30Th September, 2021

 Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 30th September, 2021. This is for your information and record.
16-11-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2021

 The Board of Directors of the Company, at their meeting held on 9th November, 2021, have, inter alia, approved the Unaudited Financial Results for the quarter and half year ended 30th September, 2021. We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and half year ended 30th September, 2021, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 3.00 p.m. and ended at 5.05 p.m. This is for your information and record.
09-11-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has issued duplicate share certificate in respect of Share Certificates reported to be lost by the shareholder. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificate are as given below: Name of the Shareholder Folio no. No. of shares Old Certificate Nos. Distinctive Nos. New Certificate No. Sachin Kumar Sharma 6342 1500 41874-41880 41888-41894 41896 71607201-71607900 71608601-71609300 71609401-71609500 209077 This is for your information and record.
09-11-2021
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Board Meeting Intimation for Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2021

 INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 9th November, 2021, to consider and approve, the unaudited financial results for the quarter and half year ended 30th September, 2021.
01-11-2021
Next Page
Close

Let's Open Free Demat Account